000			01875 a2200517 4500
005			20250517011603.0
264		0	_c20150618
008			201506s 0 0 eng d
022			_a2325-8179
024	7		_a10.3928/23258160-20150101-04 _2doi
040			_aNLM _beng _cNLM
100	1		_aOkamoto, Masahiro
245	0	0	_aChoroidal thickness and choroidal blood flow after intravitreal bevacizumab injection in eyes with central serous chorioretinopathy. _h[electronic resource]
260			_bOphthalmic surgery, lasers & imaging retina _cJan 2015
300			_a25-32 p. _bdigital
500			_aPublication Type: Comparative Study; Journal Article
650	0	4	_aAngiogenesis Inhibitors _xtherapeutic use
650	0	4	_aAntibodies, Monoclonal, Humanized _xtherapeutic use
650	0	4	_aBevacizumab
650	0	4	_aBlood Flow Velocity
650	0	4	_aBlood Pressure _xphysiology
650	0	4	_aCentral Serous Chorioretinopathy _xdiagnosis
650	0	4	_aChoroid _xphysiopathology
650	0	4	_aChronic Disease
650	0	4	_aColoring Agents
650	0	4	_aFemale
650	0	4	_aFluorescein Angiography
650	0	4	_aHeart Rate
650	0	4	_aHumans
650	0	4	_aIndocyanine Green
650	0	4	_aIntraocular Pressure _xphysiology
650	0	4	_aIntravitreal Injections
650	0	4	_aLaser-Doppler Flowmetry
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aOrgan Size
650	0	4	_aProspective Studies
650	0	4	_aRegional Blood Flow
650	0	4	_aRetina _xpathology
650	0	4	_aVascular Endothelial Growth Factor A _xantagonists & inhibitors
650	0	4	_aVisual Acuity _xphysiology
700	1		_aMatsuura, Toyoaki
700	1		_aOgata, Nahoko
773	0		_tOphthalmic surgery, lasers & imaging retina _gvol. 46 _gno. 1 _gp. 25-32
856	4	0	_uhttps://doi.org/10.3928/23258160-20150101-04 _zAvailable from publisher's website
999			_c24506293 _d24506293